Viosera Therapeutics
Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD3m (Public information from Mar 2019)
Sunnyvale California (HQ), San Francisco United States (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$150k Valuation: $2.0m | Seed | ||
N/A | Seed | ||
| Total Funding | CAD205k | ||
Related Content
Recent News about Viosera Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.